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Abstract
Purpose—Integrating HIV testing programs into substance use treatment is a promising avenue 
to help increase access to HIV testing for rural drug users. Yet few outpatient substance abuse 
treatment facilities in the United States provide HIV testing. The purpose of this study was to 
identify barriers to incorporating HIV testing with substance use treatment from the perspectives 
of treatment and testing providers in Arkansas.
Methods—We used purposive sampling from state directories to recruit providers at state, 
organization, and individual levels to participate in this exploratory study. Using an interview 
guide, the first and second authors conducted semi-structured individual interviews in each 
provider’s office or by telephone. All interviews were recorded, transcribed verbatim, and entered 
into ATLAS.ti software (ATLAS.ti Scientific Sofware Development GmbH, Berlin, Germany). 
We used constant comparison and content analysis techniques to identify codes, categories, and 
primary patterns in the data.
Findings—The sample consisted of 28 providers throughout the state, 18 from the substance use 
system and 10 from the public/ community health system. We identified 7 categories of barriers: 
environmental constraints, policy constraints, funding constraints, organizational structure, limited 
inter- and intra-agency communication, burden of responsibility, and client fragility.
Conclusions—This study presents the practice-based realities of barriers to integrating HIV 
testing with substance use treatment in a small, largely rural state. Some system and/or 
organization leaders were either unaware of or not actively pursuing external funds available to 
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them specifically for engaging substance users in HIV testing. However, funding does not address 
the system-level need for coordination of resources and services at the state level.
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Testing is an important strategy for reducing the spread of HIV for several reasons. First, the 
CDC estimates that about 20% of persons with HIV in the U.S. do not know they have it so 
may continue to unknowingly infect others.1-3 An estimated 50% of new HIV infections are 
transmitted by the 20% of persons who do not know they have HIV.2,3 Second, persons who 
are unaware of having the disease cannot benefit from antiretroviral treatment. Third, 
persons who are aware of being infected are less likely to engage in HIV risk behaviors than 
those who are not aware.2,3 Despite the many reasons testing can be beneficial, testing rates 
remain low; in fact, only 55% of adults in U.S. have ever been tested,4 and the reasons for 
non-testing remain unclear.
Integrating HIV testing programs into substance use treatment is a promising avenue to help 
increase access to HIV testing services for rural drug users.5-7 Yet as recently as 2009, only 
36% of urban and 11% of rural outpatient substance use treatment facilities in the U.S. 
provided HIV testing.8 Insufficient resources and reimbursement, complex funding 
requirements, and differences in program philosophy or treatment paradigm are some of the 
barriers to incorporating routine screening for HIV into substance abuse treatment programs 
that have been identified in other studies.9-19 However, we do not fully understand the 
barriers that rural substance use treatment providers and system administrators perceive to 
integrating HIV testing into their programs. Existing research sheds little light on the 
crucially important contextual and specific processes that may inhibit or facilitate integration 
of HIV testing with community substance abuse treatment, especially in the rural South, 
where HIV is spreading rapidly.20,21 The primary purpose of this qualitative study was to 
identify barriers to HIV testing for substance users as described by substance use treatment 
and HIV testing service administrators and providers in Arkansas.
METHODS
Setting
Arkansas is a southern state with a large percentage of rural residents and no large 
metropolitan statistical area. The total population of Arkansas is 2.6 million, and according 
to the U.S. Office of Management and Budget (OMB) definition of rural, 48% of the 
population of Arkansas live in rural areas.22 Farming/agriculture is a major component of 
the Arkansas economy, accounting for 1 out of 6 jobs and 15% of state labor income.23
Design
For this qualitative study, we used a diagnostic formative evaluation, multilevel 
approach.24’26 Diagnostic formative evaluation is a necessary pre-intervention process to 
understand the extent of current practices, the determinants of current practices, potential 
barriers and facilitators to practice change, and the feasibility and utility of potential 
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implementation intervention strategies to change practice.24 Substance abuse treatment and 
public health administrators and providers at the state, program, local, and individual levels 
were invited to engage in semi-structured qualitative interviews. This approach allowed us 
to better uncover and understand barriers and facilitators at various levels and to describe 
how each level interacts with and influences others in affecting HIV testing of substance 
users.26,27
Inclusion Criteria for Service Providers
Eligibility requirements for service administrators/providers included: (1) involved at the 
state, program, or front-line level with delivering substance abuse treatment services or HIV 
testing services (including faith-based organization and community-based organizations); 
(2) willingness to participate.
Recruiting Plan for Service Administrators/Providers
We used a sampling approach that we characterize as “assisted purposive sampling (APS),” 
a combination or mixed approach of stratified purposeful sampling and the referral element 
of chain sampling.28 Using state organizational charts, the investigative team identified 
persons who held key positions in the behavioral health and health delivery systems in 
Arkansas. These persons were contacted by a member of the investigative team by phone or 
in person and invited to participate, and they were asked for referrals to intermediate-level 
program managers and staff members. Program managers and local front-line service 
providers were then contacted by phone or email by the investigators and invited to 
participate. From state-level administrators and providers, we collected information about 
structural characteristics of their service delivery systems that could be potential barriers and 
facilitators to expansion of HIV testing such as federal/state regulations, policies, revenue 
and funding, resource allocation, scope of services, and priorities, as well as their 
perceptions of the extent and importance of undiagnosed HIV. From the program managers, 
we collected information about scope of services, HIV prevention education programs, 
work-force and client characteristics, and perceived barriers and facilitators to including 
HIV testing in substance use treatment programs. From front-line providers such as 
clinicians at local health departments and substance abuse clinics, we collected information 
about their practice, clients, staff, funding, their perceptions of the extent of undiagnosed 
HIV in the community, and need for expanded HIV testing.
Data Collection
All interviews were conducted by the same 2 members of the investigative team between 
May and December of 2010 in the provider’s office or, in a small number of cases, by 
telephone. Both interviewers are faculty with considerable expertise in social and systems 
research, qualitative methods, and the contextual aspects of substance use treatment 
delivery. Although some of our questions inquired about specific potential barriers to HIV 
testing, we began each interview with open-ended and non-specific questions concerning 
how HIV prevention is handled by their program (see Table 1). The University of Arkansas 
for Medical Sciences IRB granted a waiver of written consent and HIPAA authorization for 
service providers participating in the study. A complete description of the study was given to 
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providers prior to beginning the interview, and verbal assent to participate was obtained. No 
monetary incentives were provided.
Data Integrity
Based on recommendations by Lincoln and Guba, we took several steps to maximize the 
trustworthiness of our qualitative data.29An interview guide was used in conducting all 
interviews to ensure consistent inquiries without precluding the possibility of discovery of 
other relevant issues. The interview guides were informed by organizational and 
implementation science literature.24,25,27 All participants were told that with their 
permission the interviews would be digitally recorded and notes taken. Personal identifiers 
were removed from all notes and recordings. The interviews were transcribed verbatim, 
verified for accuracy, then entered into Atlas.ti software for data management.30
Data Analysis
The data were first read without coding to achieve an overall understanding of interview 
content.31 Constant comparison and content analysis techniques32 were then used to 
identify, code, categorize, classify, and label primary patterns in the data.33 Each 
investigator reviewed the same 5 interviews to identify top-level codes, then met to discuss 
and review each other’s work until consensus was reached on top-level codes and 
definitions. The same process was used to develop sub-codes. A codebook with definitions 
was developed by 4 members of the research team based on the first 5 interviews, and that 
codebook was then used to code all interview data.
RESULTS
Characteristics of Sample
We recruited a total of 28 providers, representative of major stakeholders in the delivery of 
substance use treatment and HIV prevention services for central, south, and east Arkansas as 
shown in Table 2. Thirteen providers were female and 11 were African American; no 
providers were Hispanic. Services offered by substance use treatment programs from which 
providers were recruited varied, including residential, medical detoxification, nonmedical 
detoxification, outpatient, intensive outpatient, and opiate substitution. These programs 
served clients from both rural and urban areas. One community substance use treatment 
center was faith-based; all were nonprofit. All providers contacted agreed to participate. 
However, after repeated attempts by phone, we were unable to make contact with 
administrators in one regional rural community health program that offers HIV testing and 
treatment services for northern and western areas of the state. Therefore, program managers 
or clinicians for that program could not be invited to participate.
Barriers
We identified 7 categories of barriers to providing HIV testing to substance users as well as 
solutions found by a few. Initial coding looked separately at the 2 delivery systems, 
substance use treatment and HIV testing, but we ultimately combined them due to the 
similarity of the types of barriers and facilitators/solutions. Separate tables were developed 
for the substance abuse treatment system and the HIV testing system that reflected data 
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themes and categories by organizational level. Level 1 refers to the state/system-level 
barriers, level 2 refers to program/structural barriers, and level 3 to individual-level barriers. 
From these tables, 7 categories were identified that crossed delivery systems. The 7 barrier 
categories are: (1) environmental constraints, (2) policy constraints, (3) funding constraints, 
(4) organizational structure, (5) limited intra- and inter-agency communication, (6) burden 
of responsibility, and (7) client fragility. A full account of the barriers/facilitators by 
delivery system is available upon request from the first author. The 7 barriers were then 
combined and classified by provider level (see Table 3). We used the same process to 
identify solutions used by some providers to overcome these barriers.
Level 1: State/System Barriers
Environmental constraints—This barrier alludes to features of the larger environment 
of the state in which the substance use treatment and HIV testing delivery systems exist and 
was alluded to by all 6 state-level administrators. We were told by top-level substance abuse 
and health services administrators that because Arkansas is a part of the Bible belt with 
conservative moral values and politics, HIV is still stigmatized, and that both HIV and 
substance abuse are associated with moral weakness and shameful behavior. Other managers 
and administrators spoke of the need for a strong, committed advocate or spokesperson at 
the top levels of state government to heighten awareness of HIV as a public health problem 
and to garner political support for funding HIV prevention, testing, and treatment services. 
In the words of 1 state-level administrator, “unless we get out there and gin up the business, 
it’s just going to stay dormant.” Consequently, he said that the state missed opportunities to 
obtain additional or external funding available at the federal level for the specific purpose of 
developing or expanding HIV programs that target drug users.
For both substance abuse and public health delivery systems, the need for services is far 
greater than the supply of funding, thus, these systems must prioritize needs in distributing 
available resources. The priority for substance use treatment providers participating in the 
study at all levels is treating addiction and facilitating recovery as indicated by the words of 
one state-level administrator:
We’re treating approximately 67% of the population that’s in need of substance 
abuse treatment right now. I’m in a dilemma. In order to treat the number of people 
we’re treating, we have to skimp, mainly on other types of stuff because those 
funds are not there.
HIV competes with several other priorities in public health in this state, which has high 
morbidity and mortality rates for other chronic diseases affecting more people in the general 
population. Because Arkansas has historically had few injecting drug users and because it 
has relatively low HIV/AIDS prevalence and incidence rates in the general population, the 
perceived need for prioritizing HIV testing is low. When asked specifically about drug 
injectors, all treatment providers in the study said they saw few injectors in their programs. 
However, this may be changing according to one administrator, “I would think it’s on the 
rise with the opiates…about 5 years ago they (injectors) were like 2.5% but now they’re 
over 5%. Opiate use and addiction is on the rise in Arkansas; it’s pharmaceuticals, not 
heroin.” This was confirmed by a methadone clinic provider, “Around 80% of our clients 
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need methadone for prescription drug addiction (oxycontin, hydrocodone, oxydone). We 
have very few injectors and they are usually older.” Lack of awareness is also a barrier, 
according to 2 health services managers. For example, one manager adds, “We have not 
seen that message in our community and have become complacent and think it’s out there in 
Africa, not HIV in Arkansas.” Therefore, low awareness, high stigma, and low rates of HIV 
result in low priority and low funding for HIV testing.
Policy constraints—There is no legislative regulation or policy addressing HIV testing in 
substance use treatment programs in Arkansas. Neither the Arkansas Department of Health 
(ADH) nor the Office of the Arkansas Division of Drug and Alcohol Prevention (OADAP) 
has written policies or requirements regarding providing testing in substance abuse 
programs. For example, HIV testing is not a state or national outcome measure for substance 
abuse treatment providers. However, programs must follow rules to remain licensed, such as 
providing HIV education and referring clients who request testing to the local public health 
unit or other organization. We were told, “As far as direct HIV education, we do what we 
call reproductive health education. And then we give them a list, in these outlined clinics, a 
list of addresses for local health departments.” However, providers said that they are not 
required to provide testing or transport their clients to a testing facility. Providers at one site 
said transporting substance use clients
…could become a barrier here anyway because if they’ve tested positive (with 
rapid test) and they need a blood test, then we got to make arrangements for them 
to go and be tested because, at that point, you don’t want to wait 21 days later to be 
tested…and that adds more cost because you have to have a guard with them to go 
there and all that kind of stuff.
A few programs do provide transportation to testing, and some programs have arrangements 
with outside agencies to provide testing on site.
Funding constraints—Different funding streams with different requirements and 
restrictions for HIV testing and HIV treatment also limit use of available funds. ADH is the 
recipient of federal funds from the Centers for Disease Control and Prevention (CDC) to 
provide HIV education and testing for Arkansas. ADH distributes some of these funds as 
grants to community-based organizations. ADH also receives Ryan White funds from the 
Health Resources and Services Administration (HRSA) to provide HIV/AIDS treatment and 
fund the AIDS Drug Assistance Program (ADAP) in Arkansas. ADH does not provide 
treatment or medication but contracts with other health care organizations to do so. 
Allotment of federal funds to states is based on number of persons living with HIV and 
AIDS in the state.34 Thus, Arkansas receives a relatively small amount of funds. Arkansas 
received $12,787,373 in federal funds in 2009.35 Few state dollars, $5,968 in 2009, augment 
federal funds for HIV prevention, testing, and treatment.35 We were told by one provider, 
“There are no state dollars. Well the legislature’s push back was, ‘Well, there’s some people 
on Medicaid, right, so if they’re HIV positive on Medicaid they’re getting their drugs paid 
for by state dollars.’”
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Level 2: Program Barriers
Organizational structure—In this small rural state, the state public health system is 
autonomous, answering directly only to the governor and legislature. The state substance use 
system is administered through the state’s Division of Behavioral Health Services, which is 
one division of a separate entity, the Arkansas Department of Human Services. This results 
in institutional silos. There is no significant infrastructure in place to facilitate collaboration 
between substance use treatment and public health programs for providing HIV testing to 
substance use clients. No central referral system or network exists. Rather, in the words of 
one state-level administrator, “the local unit director there has made that decision” in setting 
up its own schedule for days and times HIV testing is conducted for the general public and 
for referrals from substance use programs.
The limited capacity of local health units to provide testing has resulted in access problems 
for substance use programs. One residential substance use program director reported that he 
was instructed by his local health unit to send only 2 clients per week to the health unit to be 
tested, and that HIV testing in that unit was limited to one day of the week. Because they 
could only send 2 per week, many who wanted the test were unable to get it. The director 
also told us that some clients were out of treatment before receiving their test results. The 
director explained the reasons for restricted access to testing for his clients:
…but you’ve got to remember that most health departments are short-staffed or 
barely, you know, they just get by. And then they’ve got appointments that are set 
up, and if you take 10 people for STDs, they’re basically shutting your clinic down.
Limited intra- or inter-system communication—Poor inter- and intra-agency 
communication was a barrier reported both within and across systems. Only 2 or 3 of 28 
providers we interviewed in either system were cognizant of state regulations. Regional 
managers did not seem to communicate with state administrators or local managers, and 
local managers did not communicate with one another about referral barriers and possible 
solutions to testing for substance use treatment clients. All local treatment providers knew 
the address and phone number of the local health unit, but only 2 could provide information 
about the days and times the local health unit offered testing. Few knew anything about 
rapid testing. In 1 treatment program, managers did not know how their clinical staff 
handled HIV testing.
Level 3: Individual Barriers
Burden of responsibility—Substance use program managers and clinicians expressed 
concern and uncertainty about the extent of their responsibilities if they were to provide HIV 
testing internally. Such concerns included responsibility for obtaining confirmatory testing, 
providing linkage to services for those who test positive, reporting requirements for 
infectious disease, protecting client confidentiality, obtaining treatment medicines, and 
providing clients with psychological support. Both substance use and HIV program staff 
voiced concern that substance use disease (SUD) treatment staff members may not feel 
adequately trained to manage the process of giving substance use clients positive results. For 
example, one counselor said, “We don’t do medical here. We’re behavioral health. We don’t 
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do medical. So if they have a medical concern, we refer them.” A public health manager told 
us, “Some have said they had rather tell a person that their child had died than tell them that 
they themselves have HIV.”
Client fragility—Some treatment clinicians expressed concerns about client fragility, 
saying persons in treatment were too angry, anxious, or confused to deal with the possibility 
of having HIV. Some program managers said they feared introducing HIV testing could 
push clients “over the edge” and/or jeopardize their recovery. Others said because some 
clients in treatment were under duress, they were already dealing with too many other 
stressful issues to face the possibility of having HIV. Clinicians and managers also 
expressed concern that some clients do not have sufficient coping abilities or inner resources 
to manage a positive result. This concern was expressed by one provider who said:
If you end up with a positive result, you effectively have a mental case on your 
hand. And you have no idea how that person is going to react. It can be anything 
from sobbing, destitute, suicidal to ‘well at least I don’t have AIDS.’
This concern was also voiced by a provider at another facility, “I’m the client, I’m trying to 
get well and I’m almost suicidal anyway just because of life issues and now you fling on me 
this other thing (HIV test). I mean if I wasn’t suicidal, I would become suicidal.”
Solutions and Facilitators
One of the organizations in our sample was a federally qualified health center (FQHC) that 
provided on-site HIV education, testing, and counseling services for substance use programs 
in 10 counties through a special program that was funded by a Substance Abuse and Mental 
Health Services Administration (SAMHSA) grant for the specific purpose of providing 
outreach and testing services to substance users and other high-risk populations. They 
estimate they conducted 2000 HIV tests in the past year through this program, not only to 
substance users in treatment but through outreach activities to out-of-treatment substance 
users as well. Below, we describe solutions used by this FQHC to overcome barriers to 
testing at various organizational levels.
Level 1: State/System Facilitators
Lack of regulatory barriers—Unlike some states, Arkansas does not require written 
consent for HIV testing, except for testing related to occupational exposure.36 Nor does the 
state have regulations or restrictions about rapid HIV testing. The lack of these requirements 
enabled the FQHC to use non-clinical staff, a mobile van, and rapid testing for their outreach 
program.
External funding—This organization has sought and received external funding from 
SAMHSA for the specific purpose of providing HIV education and testing outreach to 
substance users. These funds eliminate not only the cost barrier but also the barrier of 
competing needs and priorities. The SAMHSA grant is for 5 years and FQHC leaders appear 
confident it will be renewed.
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Level 2: Program Facilitators
Committed leadership—Strong support for the HIV testing program comes from the top 
down in this FQHC. A division of the organization is devoted to a full range of services for 
persons with HIV and those at risk of acquiring HIV. Leaders actively pursue available 
funds to test high-risk target groups such as drug users and minorities. They are funded by 
the federal Ryan White program, CDC, SAMHSA, and ADH for different kinds of services 
related to HIV.
Strong internal and external referral network—The parent organization (FQHC) is 
an umbrella for wrap-around HIV prevention, testing, and treatment services through 
separate funding mechanisms and divisions. The FQHC provides central organization, a 
strong referral network, and actively seeks out contracts and collaboration with treatment 
centers and other providers in its catchment area. It is also a member of an AIDS Education 
and Training Center, which facilitates inter-organizational communication and education.
Dedicated program—The dedicated program, made possible by external funding, has one 
purpose and priority: testing substance users and linking them to treatment services. The 
program provides expertise, staff, incentives for clients (such as t-shirts and gift cards), 
transportation, and linkage to HIV services at no cost to substance abuse programs and 
clients. However, most substance abuse programs in the state do not benefit from this 
program, since the program’s catchment area includes only 4 counties.
Level 3: Individual
Dedicated staff—External funding makes it possible for the HIV testing program at the 
FQHC to have a dedicated staff without competing job responsibilities. The dedicated 
program staff contacts substance use programs in its service area and contracts with them to 
provide free HIV education, testing, and counseling to their clients on a monthly basis. 
Having an outside agency provide testing also alleviates many concerns substance abuse 
treatment counselors expressed about conducting testing themselves. Substance abuse 
managers and clinicians who benefited from the dedicated program and staff said they like 
this approach because they felt the HIV program staff had the expertise and training to 
answer clients’ questions about HIV, offer support to clients who test positive, and provide 
information about linkage and referrals. One program manager explained, “Because they 
have the expertise in the area, and that’s what they’re known to do. I think that partnership 
works well.” Another substance use treatment manager said, “I just like the idea of someone 
else coming in.” It is also important to note that having people from an outside agency 
involved in providing HIV testing could also be beneficial since clients who want to be 
tested may be reluctant to reveal their condition to local staff because of privacy concerns. 
In small rural communities, local service providers and service users are often members of 
the same kinship and social networks. As one substance use counselor expressed, “I think 
it’s a confidentiality issue. I think that they (clients) are more apt to work with somebody 
outside that would protect their confidentiality.”
Social marketing—The HIV program staff use social marketing to increase acceptability 
among substance abuse clients and reduce stigma associated with HIV testing. Opt-out HIV 
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testing is routinized in that it is offered to every client. T-shirts printed with “I know, do 
you?” and gift cards are given to those who are tested, and managers of substance use 
treatment centers where the FQHC has conducted the testing program report that the t-shirts 
and the gift cards are both very popular among clients at the centers. As a result, testing has 
become a more socially accepted norm in these programs, and stigma is lessened. One 
program manager described how her clients responded this way, “While I’m here I’m going 
to get tested like everybody else and I’m going to get a t-shirt and I may get a gift card. So 
it’s not a stigma.” All 4 substance abuse managers and clinicians with treatment programs 
contracting with the HIV program said most of their clients participated and liked the 
program.
DISCUSSION
Effective structural intervention requires a locally contextualized approach based on a 
thorough assessment of existing individual and institutional norms and practices, 
relationships and interrelationships across multiple levels, and potential barriers and 
facilitators to intervention adoption and implementation.24,37-42 Interventions to increase 
HIV testing for substance users are highly dependent on specific contextual factors, such as 
capacities, expertise, funding, and socio-political climate.40
Routine testing for HIV has been successfully integrated with substance use treatment 
programs and diverse primary care settings in other rural states. Rapid testing for HIV was 
integrated with detoxification and outpatient substance abuse treatment programs 
participating in the National Institute on Drug Abuse (NIDA) Clinical Trials Network 
(CTN) in 2 counties in South Carolina.43 The CTNs provide support and research funding to 
foster academic/community collaboration for the development and transfer of new treatment 
options to providers and clients of community treatment centers. Arkansas does not 
participate in the NIDA CTN. The National Association of Community Health Centers, Inc. 
has developed a protocol for implementing routine HIV testing in their clinics that has been 
successful in community health centers in Mississippi, North Carolina, and South 
Carolina.44 Routine testing has also been successfully integrated in emergency departments 
and other primary care settings in Alabama, Georgia, Kentucky, North Carolina, South 
Carolina, and Tennessee with support of the federally funded AIDS Education and Training 
Centers (AETCs) program.45 The common factor in the success of all of the above examples 
is collaboration and support from outside agencies/organizations.
HIV testing was not provided by substance abuse treatment staff by any of the programs in 
this study. However, HIV testing was provided as part of regular services offered by local 
public health units and community health centers; at special testing outreach events and 
programs sponsored by the state health department in partnership with community-based 
organizations; and by one program funded directly by SAMHSA to provide pre-intervention 
HIV services to high-risk populations, including drug users. The Arkansas Department of 
Health (ADH) does not use rapid tests for most HIV tests but uses the enzyme-linked 
immunosorbent assay test (ELISA), also known as the standard test, because a blood 
specimen allows testing not only for HIV but also for syphilis and hepatitis. Rapid testing 
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was used by other organizations in clinical and non-clinical settings. According to a recent 
report, ADH conducted 66,971 HIV tests in 2010.46
The barriers we identified are similar to those reported in National Drug Abuse Treatment 
Clinical Trials Network programs and by providers in other settings such as emergency 
rooms, prenatal clinics, and community-based organizations.10-13,17 However, 
characteristics that distinguished programs offering testing from those who do not in 
national studies differed in some respects in our study. For example, unlike reports from 
other studies, testing in Arkansas was not provided by programs offering opiate substitution, 
medical detoxification, or programs with licensed medical staff.10-13 We speculate this is 
likely in Arkansas because only 13.7% of HIV/AIDS cases cumulative through 2008 are 
attributed to injection drug use.1
Some programs have found solutions that could transfer to other states and systems facing 
similar barriers. Two solutions stand out and are linked: (1) leadership/vision/commitment at 
the top level of an organization, and (2) external funding. Leadership is required for 
organizational change to occur. Integration of HIV testing with other health services requires 
formation of partnerships at the city, county, and state levels between local health 
departments, community-based organizations, and providers.37 Some system and/or 
organization leaders were either unaware of or not actively pursuing external funds that are 
available to them specifically for engaging substance users in HIV testing.
Arkansas is not alone in not taking advantage of available funds. In a national survey of 
substance abuse programs that participate in the National Drug Abuse Treatment Clinical 
Trials Network, Brown and colleagues reported that HIV-related services were absent in 
many programs even though funding was available to provide such services.13 Kritz et al38 
also reported a significant discrepancy in funding availability and funds received by 
substance abuse treatment programs for providing HIV-related services. At the very least, 
these findings indicate the strong need for better communication between federal and state 
substance abuse administrators about funding opportunities for delivering these services. 
State leaders could also better educate program leaders about special funds and how to 
obtain them.
On the other hand, one organization in Arkansas used external funds to develop a highly 
successful program targeting substance users. Such funding could be a solution for other 
organizations and other states facing similar resource barriers. Leadership can result in 
external funding; external funding results in dedicated programs and dedicated staff; 
dedicated programs and staff alleviate barriers of competing priorities, provider burden, and 
provider concerns about clients. It is also possible that if more tests were conducted, more 
persons with HIV would be identified, thus affecting state-reported HIV/AIDS incidence 
and prevalence rates. This, in turn, could result in the state becoming eligible for increased 
federal funding for HIV testing and treatment.
However, external funding does not address the systems-level need for coordination of 
services. Lack of coordination results in fragmentation or duplication of services and 
decreased access for those in need of services.41 System silos create barriers that limit 
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coordination of resources and services, especially in rural states with limited access to HIV 
testing and services. In Arkansas, formal coordination of substance use treatment and HIV 
prevention and testing services would increase sharing of information and improve 
efficiency and access to services.
Written guidelines foster formal interactions between organizations. Studies have shown that 
state guidance (policies, guidelines, regulations) is positively related to the provision of 
HIV-risk assessment, counseling, testing, and other infection-related services by substance 
use programs.13,38 Even though Arkansas’ organization of services may not provide written 
guidelines or formalize interactions between substance use and HIV testing delivery 
systems, inter-departmental and agency outreach is possible and can be an effective strategy 
for increasing awareness and collaboration. The success of inter-organization outreach was 
demonstrated by the FQHC example in our study, which had established strong 
collaborative arrangements with substance use programs in its catchment area to provide 
HIV testing services.
One of our key findings is the preference of substance use program managers and providers 
for having external program staff come in to conduct HIV counseling and testing. They felt 
external providers had the expertise and experience needed to test and, more importantly to 
them, give test results to their clients. Expertise appeared to be even more important to 
substance abuse treatment providers than relief from the additional work conducting testing 
themselves would entail.
Limitations of our study include the possibility that our results cannot be generalized to 
other states or delivery systems due to our small sample size and unique setting. Providers 
we could not reach after repeated attempts to contact are not included in this study. Thus, 
our findings may not be representative of all substance abuse and HIV testing providers in 
Arkansas. This being said, other states may be similar to Arkansas in that they are 
predominantly rural, have small populations, and have low state funding for HIV and 
substance use treatment. Our findings will be more relevant to such states and less relevant 
to more urban states and states with more state and federal funding for programs given their 
higher rates of HIV. A major strength of this study is that our sample was comprehensive 
overall in representing key stakeholders from all organizational levels across the state.
CONCLUSION
This paper presents the practice realities of integrating HIV testing with substance abuse 
treatment in a small rural state with limited resources and capacity. Given the comparatively 
low rates of HIV/AIDS as compared to the extent of other chronic diseases in Arkansas, it is 
not surprising that HIV-related services do not have higher priority. In a state with limited 
resources, allocation of resources is determined by need and need is not considered greatest 
for HIV prevention and treatment at the moment. However, funding barriers are not 
immutable if providers are aware of and utilize all funds available to them.
Wright et al. Page 12














The work described in this manuscript was supported by a research grant (award number R01DA024575) to Dr. 
Katharine Stewart from the National Institute on Drug Abuse. It was also supported in part by the Arkansas Center 
for Minority Health Disparities (award number P20MD002329 from the National Institute on Minority Health and 
Health Disparities), the Arkansas Prevention Research Center (award number 1U48DP001943 from the Centers for 
Disease Control and Prevention) and by the UAMS Translational Research Institute (award number 
1UL1RR029884 from the National Center for Advancing Translational Science). The content is solely the 
responsibility of the authors and does not necessarily represent the official views of the funding Institutes and 
Centers, the National Institutes of Health, or the Centers for Disease Control and Prevention.
References
1. Centers for Disease Control and Prevention. Vital signs: HIV testing and diagnosis among adults –
United States, 2001-2009. Morbidity and Mortality. Dec 3.2010 
2. Hall HI, Holtgrave DR, Maulsby C. HIV transmission rates from persons living with HIV who are 
aware and unaware of their infection. AIDS. 2012; 26(7):893–896. [PubMed: 22313960] 
3. Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in 
persons aware and unaware they are infected with HIV in the united states: Implications for HIV 
prevention programs. J Acquir Immune Defic Syndr. 2005; 39:446–453. [PubMed: 16010168] 
4. Centers for Disease Control and Prevention. HIV Testing at CDC-Funded Sites, United States, 
Puerto Rico, and the U S Virgin Islands, 2008-2009. Atlanta, GA: U.S. Department of Health and 
Human Services; Jul. 2011 
5. Sorensen JL, Copeland AL. Drug abuse treatment as an HIV prevention strategy: A review. Drug 
Alcohol Depend. 2000; 59(1):17–31.10.1016/S0376-8716(99)00104-0 [PubMed: 10706972] 
6. Metzger DS, Navaline H. HIV prevention among injection drug users: The need for integrated 
models. J Urban Health. 2003; 80(4 suppl 3):iii59–iii66. [PubMed: 14713672] 
7. Metzger DS, Navaline H, Woody GE. Drug abuse treatment as AIDS prevention. Public Health-
London-Society of Public Health. 1998; 113:97–106.
8. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health 
Statistics and Quality. The N-SSATS report: HIV services offered by substance abuse treatment 
facilities. Rockville, MD: SAMHSA; Dec 1. 2010 
9. Sexton RL, Carlson HA, Falk RS, Leukefeld C, Booth B. Barriers to formal drug abuse treatment in 
the rural south: A preliminary ethnographic assessment. J Psychoactive Drugs. 2008; 40(2):121–
129. [PubMed: 18720660] 
10. Bogart LM, Howerton D, Lange J, et al. Provider-related barriers to rapid HIV testing in U.S. 
urban non-profit community clinics, community-based organizations (CBOs) and hospitals. AIDS 
Behav. 2010:697–707.10.1007/s10461-008-9456-3 [PubMed: 18770022] 
11. Burke RC, Sepkowitz KA, Bernstein KT, et al. Why don’t physicians test for HIV? A review of 
the US literature. AIDS. 2007; 21(12):1617–1624.10.1097/QAD.0b013e32823f91ff [PubMed: 
17630557] 
12. Brown LS Jr, Kritz S, Goldsmith RJ, et al. Health services for HIV/AIDS, HCV, and sexually 
transmitted infections in substance abuse treatment programs. Public Health Rep. 2007; 122(4):
441–451. [PubMed: 17639646] 
13. Brown LS Jr, Kritz SA, Goldsmith RJ, et al. Characteristics of substance abuse treatment programs 
providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: 
The national drug abuse treatment clinical trials network. J Subst Abuse Treat. 2006; 30(4):315–
321.10.1016/j.jsat.2006.02.006 [PubMed: 16716846] 
14. Borders TF, Booth BM. Research on rural residence and access to drug abuse services: Where are 
we and where do we go? J Rural Health. 2007; 23(Suppl 1):79–83.10.1111/j.
1748-0361.2007.00128.x [PubMed: 18237329] 
15. Kates J, Levi J. Insurance coverage and access to HIV testing and treatment: Considerations for 
individuals at risk for infection and for those with undiagnosed infection. Clin Infect Dis. 2007; 
45(Supplement 4):S255–S260.10.1086/522547 [PubMed: 18190296] 
Wright et al. Page 13













16. Pence BW, Reif S, Whetten K, et al. Minorities, the poor, and survivors of abuse: HIV-infected 
patients in the US deep South. South Med J. 2007; 100(11):1114–1122.10.1097/01.smj.
0000286756.54607.9f [PubMed: 17984744] 
17. Pollack HA, D’Aunno T, Lamar B. Outpatient substance abuse treatment and HIV prevention: An 
update. J Subst Abuse Treat. 2006; 30(1):39–47.10.1016/j.jsat.2005.09.002 [PubMed: 16377451] 
18. Bond L, Lauby J, Batson H. HIV testing and the role of individual- and structural-level barriers 
and facilitators. AIDS Care. 2005; 17(2):125–140. [PubMed: 15763709] 
19. Strickland J, Strikland DL. Barriers to preventive health services for minority households in the 
rural south. J Rural Health. 1996; 12(3):206–217. [PubMed: 10162852] 
20. Reif S, Geonnotti KL, Whetten K. HIV infection and AIDS in the deep South. Am J Public Health. 
2006; 96(6):970–973.10.2105/AJPH.2005.063149 [PubMed: 16670228] 
21. Centers for Disease Control and Prevention. HIV Prevalence Estimates - United states, 2006. 
MMWR Weekly. Oct 3; 2008 57(39):1073–1076. Available at: http://www.cdc.gov/mmwr/
preview/mmwrhtml/mm5739a2.htm. 
22. United States Department of Agriculture. [June 15, 2011] USDA Economic Research Service 
Rural definitions: data documentation and methods. Sep 4. 2007 Available at: http://
www.ers.usda.gov/Data/Ruraldefinitions/Documentation.htm
23. University of Arkansas, Cooperative Extension Service (UAEX). [August 10, 2011] Economic 
contribution of Arkansas agriculture 2011. Available at: University of Arkansas, Division of 
Agriculture web site: http://division.uaex.edu/news_publications/
Economic_Contribution_2011.pdf
24. Curran G, Mukherjee S, Allee E, Owen R. A process for developing an implementation 
intervention: QUERI series. Implement Sci. 2008; 3(1):17. [PubMed: 18353186] 
25. Stetler CB, Legro MW, Wallace CM, et al. The role of formative evaluation in implementation 
research and the QUERI experience. J Gen Intern Med. 2006; 21(Suppl 2):S1–S8. [PubMed: 
16637954] 
26. Shortell SM. Increasing value: A research agenda for addressing the managerial and organizational 
challenges facing health care delivery in the united states. Med Care Res Rev. 2004; 61(3_suppl):
12S–30S.10.1177/1077558704266768 [PubMed: 15375281] 
27. Proctor EK, Landsverk J, Aarons G, Chambers D, Glisson C, Mittman B. Implementation research 
in mental health services: An emerging science with conceptual, methodological, and training 
challenges. AdminPolicy Ment Hlth. 2009; 36(1):24–34.
28. Miles, MB.; Huberman, AM. Qualitative Data Analysis. 2. Thousand Oaks, CA: SAGE 
Publications; 1994. 
29. Lincoln, YS.; Guba, EG. Naturalistic Inquiry. Newbury Park, CA: Sage Publications; 1985. 
30. ATLAS ti Scientific Software Development GmbH (2003-2009). Berlin, Germany: 
31. Charmaz, K. Grounded theory in the 21st century: applications for advancing social justice studies. 
In: Denzin, NK.; Lincoln, YS., editors. The SAGE Handbook of Qualitative Research. 3. 
Thousand Oaks, CA: SAGE Publications; 2005. p. 507-535.
32. Hsieh H, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005; 
15(9):1277–1288.10.1177/1049732305276687 [PubMed: 16204405] 
33. Bradley EH, Curry LA, Devers KJ. Qualitative data analysis for health services research: 
Developing taxonomy, themes, and theory. Health Serv Res. 2007; 42(4):1758–1772.10.1111/j.
1475-6773.2006.00684.x [PubMed: 17286625] 
34. Mansergh G, Valdiserri RO, Yakovchenko V, Koh H. Aligning resources to fight HIV/AIDS in the 
united states: Funding to states through the US department of health and human services. JAIDS J 
Acquired Immune Defic Syndromes. 2012; 59(5):516–522.
35. KAISER Family Foundation. [July 16, 2012] Arkansas - Kaiser State Health Facts. 2012. 
Available from: http://www.statehealthfacts.org/profileind
36. [February 26, 2008] Arkansas Code Annotated (ACA), section code 20-15-901. Available at: 
http://170.94.58.9/NXT/gateway.dll?f=templates&fn=default.htm&vid=blr:code
37. Hauschild B, Miller V, Strobos J. Municipal scale-up of HIV testing in the United States: Current 
status, challenges and opportunities from a multi-stakeholder perspective. Ann Forum 
Collaborative HIV Res. 2011; 13(4):1–8.
Wright et al. Page 14













38. Kritz S, Brown LS Jr, Goldsmith RJ, et al. States and substance abuse treatment programs: 
Funding and guidelines for infection-related services. Am J Public Health. 2008; 98(5):824–826. 
[PubMed: 18381995] 
39. Piot P, Bartos M, Larson H, Zewdie D, Mane P. Coming to terms with complexity: A call to action 
for HIV prevention. Lancet. 2008; 372(9641):845–859.10.1016/S0140-6736(08)60888-0 
[PubMed: 18687458] 
40. Sumartojo E. Structural factors in HIV prevention: Concepts, examples, and implications for 
research. AIDS. 2000; 14(Supplement 1):S3–S10. [PubMed: 10981469] 
41. Shigayeva A, Atun R, McKee M, Coker R. Health systems, communicable diseases and 
integration. Health Policy Plann. 2010; 25(suppl 1):i4–i20.10.1093/heapol/czq060
42. Rotheram-Borus MJ, Swendeman D, Chovnick G. The past, present, and future of HIV prevention: 
Integrating behavioral, biomedical, and structural intervention strategies for the next generation of 
HIV prevention. Annu Rev Clin Psychol. 2009; 5:143–167.10.1146/annurev.clinpsy.
032408.153530 [PubMed: 19327028] 
43. Haynes L, Korte J, Holmes B, et al. HIV rapid testing in substance abuse treatment: 
Implementation following a clinical trial. Eval Program Plann. 2011; 34(4):399–406. [PubMed: 
21367457] 
44. Myers JJ, Modica C, Dufour MSK, Bernstein C, McNamara K. Routine rapid HIV screening in six 
community health centers serving populations at risk. J General Intern M. 2009; 24(12):1269–
1274.
45. Myers JJ, Bradley-Springer L, Dufour MSK, et al. Supporting the integration of HIV testing into 
primary care settings. Am J Public Health. 2012; 102(6):e25–e32.10.2105/AJPH.2012.300767 
[PubMed: 22515867] 
46. Arkansas Department of Health (ADH). [June 8, 2012] ADH Annual Report 2010. Available at: 
http://www.healthyarkansas.com/
47. Bini EJ, Kritz S, Brown LS Jr, et al. Hepatitis B virus and hepatitis C virus services offered by 
substance abuse treatment programs in the United States. J Subst Abuse Treat. 2012; 42(4):438–
445.10.1016/j.jsat.2011.09.007 [PubMed: 22035702] 
Wright et al. Page 15

























Wright et al. Page 16
Table 1
SUD Treatment Provider Interview Guide
1 a. Grand Tour Question for state-level administrators: “Tell me about how HIV prevention is handled by substance abuse 
treatment programs in Arkansas.”
(Make sure that injection risks, and sex risks as well as other types of prevention programs or sessions are addressed)
b. Grand Tour Question for program managers/front-line staff: “Tell me about how HIV prevention is handled by your 
program(s).
(Make sure that injection risks, and sex risks as well as other types of prevention programs or sessions are addressed)
a. If HIV prevention is not addressed, ask
• What are the main reasons you think it is not?
• What do you see as the barriers to this?
b. If HIV prevention is addressed, ask what kinds of HIV prevention services are provided?
I. Who delivers HIV prevention services?
• staff members (medical staff, counselors, clerical, admission/discharge staff members)?
• Or is it provided by outside agencies/persons (such as ADH)?
II. At what point during the treatment process is HIV prevention addressed?
III. What content is included in the prevention program?
IV. How is prevention delivered? (one-on-one, groups, pamphlets, videos)
V. Do the services differ by type of SUD program (e.g., residential, outpatient, detoxification)?
2 What about testing for HIV?
a. If not provided, what are the main reasons why not?
b. If provided, what is the process? (also check by type of SUD program)
I. Who is tested? At what point in treatment is testing done? What kind of test is done (standard or rapid)? How 
often is testing done? Who conducts the tests (internal/external)? Who pays for tests?How are initial positive tests 
confirmed? Who gives the client test results? How are referrals handled?
II. How many are tested? How many are positive?
III. How is mandatory reporting handled?
IV. How is confidentiality managed?
V. How is the test documented in patient chart?
3 What do you see as barriers to routine rapid testing for HIV in SUD treatment programs overall? In your program (or types of 
programs your organization offers)?
4 What would make it easier to incorporate HIV testing in SUD treatment programs?
5 What are your thoughts about opt-in versus opt-out testing?
6 Are there counseling staff in your program (or other program administrators) that you would recommend I talk to about these 
issues? It is really important that I talk to people who have lots of divergent opinions.
Thank you
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TABLE 2
Characteristics of Sample
System Level Role Substance Abuse Treatment (N) HIV Prevention and Testing (N)
I. State-level administrators 3 3
II. Senior organization/program managers 8 2
III. Team leaders or unit managers 5 2
IV. Individual Provider 2 3
TOTALS 18 10
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TABLE 3
Major Provider Barriers to HIV Testing
Organization Level Barrier Description
State/System
1) Environmental constraints Larger environment in which substance use treatment and HIV testing delivery 
systems exist
• Conservative moral values and politics
• Lack of strong advocate to heighten awareness and garner political 
support
• Competing health needs and priorities
• Few injecting drug users and low HIV/AIDS incidence and prevalence 
rates compared to other states
2) Policy constraints State regulations and requirements
• No state legislative regulation or policy addressing HIV testing in 
substance use treatment programs
3) Funding constraints Limited revenues and resources to pay for expanding HIV testing
• Complexity and limitations of separate federal funding streams for 
testing and treatment
• Very limited overall funding for substance use treatment and HIV 
testing programs as allotment and distribution of federal dollars is based 
on number of persons living with AIDS in the state
• Little state funding for substance use or HIV testing programs to 
supplement federal funds
• Competing health needs and priorities in state for distribution of 
available funds
• Few programs receive special funding available for testing high-risk 
populations
– lack of awareness,
– lack of knowledge about how to obtain these funds
– do not meet eligibility requirements
Program
4) Organizational structure Program culture, internal processes and decision-making, and external partnerships
• Health services system silos
– No infrastructure for coordinating services
– No incentive for coordinating services
– No central referral system
• Scattershot approach: up to each local program to make referral 
arrangements for HIV testing for substance abuse program clients
• Inefficient and ineffective use of limited resources
• Limits access to testing for substance users
5) Limited intra-and inter-
agency communication
• No shared goals or leadership
• No shared responsibility
• No shared patient information
• No shared data collection
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Organization Level Barrier Description
• Little shared knowledge and training
Individual
6) Burden of responsibility Provider concerns and uncertainty about extent of their responsibility if HIV testing 
was provided by their program or agency
• Process concerns
– Obtaining confirmatory testing
– Providing linkage to services for clients who test positive
– Reporting requirements
– Protecting client confidentiality
– Obtaining treatment medicines
– Providing clients necessary psychological support
• Self-efficacy concerns
– Feel inadequately trained to give clients positive test results
7) Client fragility Providers fear introducing HIV testing could threaten clients recovery or be too 
much for them to handle
• Too anxious, too angry, too confused
• May jeopardize sobriety
• Involuntary commitment to treatment
• Short-stay treatment; discharged before obtaining test results
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